UNSPSC 51101906: Proguanil

This classification denotes a dihydrofolate reductase inhibitor and antimalarial agent with the molecular formula C11H16ClN5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S61K3P7B2V, chemically known as sn 12,837 but generally known as chlorguanide, which bears US NIH Compound Identifier 6178111. European Medicines Agency schedules Proguanil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10079MIG.

UNSPSC 51101906 Proguanil is a Commodity code that nominally covers a specific antimalarial pharmaceutical, yet recent state and local opportunities show little procurement activity aligned with proguanil itself. Instead, the code appears tagged on solicitations for broader pharmaceutical and medical supply categories—generic multi-source pharmaceuticals, naloxone, and emergency medical consumables—suggesting either misclassification in the posting system or divergence between the code's narrow definition and actual purchasing practice. State and local governments buying under this code or its associated tags are seeking pharmaceutical products through cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance), county health departments (Seminole County, Florida), municipal fire rescue divisions (City of Tampa), and state health and human services commissions (Texas HHS). The work ranges from direct pharmaceutical manufacturer contracting for prescription fulfillment to procurement of emergency medical supplies and OTC products, with quantities typically measured in thousands of units annually and contract terms of one to two years with renewal options.

Geographic activity appears concentrated in Florida, Minnesota, Texas, and Oregon, based on recent postings. Representative opportunities include Seminole County's IFB60459723LAS seeking 1,900 units of naloxone and 800 drug deactivation systems annually (response deadline July 26, 2023); the City of Tampa's IFB 26P00145 for 169 line items of medical and first aid supplies for the Fire Department Rescue Division with an estimated contract value of $700,000 (deadline March 13, 2026); the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products through authorized wholesalers (deadline March 26, 2026); and the Texas Health and Human Services Commission's RFI HHS0017013 regarding direct-to-manufacturer prescription programs (deadline April 3, 2026). The Tampa and Minnesota opportunities are sheltered or multi-award competitive processes; the Texas RFI is exploratory market research preceding formal procurement. No specific proguanil demand signals appear in recent postings.